Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transfusion of Red Blood Cells (RBC), Tranexamic Acid (TXA) and Fibrinogen Concentrate (FC) for Severe Trauma Hemorrhage at Pre-hospital Phase of Care. A Pilot Trial.

NCT03780894 is registered in ClinicalTrials.gov with Banc de Sang i Teixits as lead sponsor.

NCT NCT03780894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03780894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transfusion of Red Blood Cells (RBC), Tranexamic Acid (TXA) and Fibrinogen Concentrate (FC) for Severe Trauma Hemorrhage at Pre-hospital Phase of Care. A Pilot Trial.
Lead sponsor
Banc de Sang i Teixits
Phase
Phase 1/2
Overall status
Completed
Start date
November 21, 2018
Completion date
January 11, 2022
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polytrauma, traumatic hemorrhage